Genelux CFO Lourie Zak resigns; Matt Pulisic appointed CFO with $410k salary, 275k option

GENELUX Corp

Lourie Zak resigned as CFO effective Jan 29, 2025; separation includes $180k cash payment (6 months salary) and advisory role through Aug 29, 2025.
Matt Pulisic appointed CFO effective Jan 30, 2025; previously VP Finance at Arrowhead Pharmaceuticals.
Pulisic receives base salary of $410,000/year, target bonus of 40% of base, and option to purchase 275,000 shares at $3.95/share.
Option vests over 4 years (25% after one year, then monthly); full acceleration upon change in control.
Pulisic eligible for severance: 6 months base salary without cause, 12 months base salary if termination within change in control period.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Matt Pulisic

Chief Financial Officer

GNLX · GENELUX Corp

Effective: 2025-01-30
Filed: February 3, 2025, 6:59 PM ET

On February 3, 2025, the Company announced the appointment of Matt Pulisic as the Company’s Chief Financial Officer, effective as of January 30, 2025 (the “ Effective Date ”).

Departed

Lourie Zak

Chief Financial Officer

GNLX · GENELUX Corp

Effective: 2025-01-29
Successor: Matt Pulisic
Filed: February 3, 2025, 6:59 PM ET

On January 29, 2025 (the “ Separation Date ”), Lourie Zak resigned as Chief Financial Officer of Genelux Corporation (the “ Company ”), effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Matt Pulisic was appointed as Chief Financial Officer at GENELUX Corp.

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

On February 3, 2025, the Company announced the appointment of Matt Pulisic as the Company’s Chief Financial Officer, effective as of January 30, 2025 (the “ Effective Date ”).

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Lourie Zak resigned as Chief Financial Officer at GENELUX Corp.

Action: resigned
Role: Chief Financial Officer

Exact text from the filing

On January 29, 2025 (the “ Separation Date ”), Lourie Zak resigned as Chief Financial Officer of Genelux Corporation (the “ Company ”), effective immediately.

View on SEC.gov

GENELUX Corp filing history →

Source: SEC EDGAR

accession 0001493152-25-004554

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.